Search PubMed⌕ Search

Biomedical subjects

Claude Pichard

Publications and source records attributed to Claude Pichard.

70 records · Page 4Linked to original sources

Nutrition status in patients younger and older than 60 y at hospital admission: a controlled population study in 995 subjects.

OBJECTIVE: Body weight and body mass index are easily obtainable indicators of nutrition status but do not provide information on changes in fat-free mass (FFM) and fat mass with age. In this prospective controlled study, we investigated whether body composition measurements were useful in identifying moderately or severely depleted patients, as judged by the Subjective Global Assessment at hospital admission. In addition, the subjects were grouped by age (< or =60 and >60 y) to determine whether there was an effect of aging on the prevalence of malnutrition. METHODS: Nine hundred ninety-five consecutive patients were evaluated for malnutrition by body mass index, serum albumin, Subjective Global Assessment, and 50-kHz bioelectrical impedance analysis and compared with 995 age- and height-matched healthy volunteers for FFM and fat mass. RESULTS: A body mass index less than 20 kg/m(2) was found in 17.3% of patients. Low albumin (< or =34.9 g/L) was found in 14.9% of all patients and 23.7% of those older than 60 y. In contrast, 23.1% and 38.3% of all patients were severely and moderately depleted, respectively, according to the Subjective Global Assessment. FFM was significantly lower in severely depleted men and women and moderately depleted women (P < or = 0.001), and fat mass was significantly higher (P < or = 0.05) in well-nourished patients than in volunteers. Patients older than 60 y had lower FFM and higher fat mass than did patients 60 y or younger or volunteers (P < or = 0.001). CONCLUSION: The prevalence of malnutrition was greater in patients older than 60 y than in those 60 y and younger. Patients classified as severely depleted according to the Subjective Global Assessment were depleted of FFM. Body composition measurement can help to identify patients with low FFM and high fat mass.

Adipose Tissue↗

Body composition: what's new?

PURPOSE OF REVIEW: Body mass index has been shown to be an imprecise measurement of fat-free and fat mass, and provides no information if weight changes occur as a result of a decrease in fat-free mass or an increase in fat mass. RECENT FINDINGS: Non-invasive body composition methods (i.e. bioelectrical impedance analysis, air displacement plethysmography) can now be used to monitor fat-free and fat mass with weight gain and loss, and during aging. This review discusses body composition measurements in terms of ethnic differences, physical activity, and age, and the limitations of bedside techniques in obesity and abnormal hydration status. SUMMARY: An assessment of the fat-free and fat mass provides valuable information about changes in body composition with weight gain or loss and physical activity, and during aging. Non-invasive bedside techniques can now be used to evaluate the nutritional status of healthy and ill individuals.

Adipose Tissue↗

Assessment of nutritional status in organ transplant: is transthyretin a reliable indicator?

Transthyretin has been proposed as a nutritional index to screen for malnutrition and monitor the metabolic response to dietary intervention. In the presence of inflammation, circulating transthyretin levels drop regardless of optimal caloric intake. In this case, due to its rapid turnover, the pattern of transthyretin, monitored by means of repeated measures, could indicate the metabolic status (catabolism vs. anabolism). The aim of this review is to investigate the possible role of transthyretin as a nutritional parameter in organ transplantation. The literature on nutritional assessment in transplantation was reviewed and all the data regarding circulating transthyretin levels were analyzed. It appears that, on the one hand, the transthyretin level reflects closely dietary manipulations; on the other hand, it is affected by the inflammatory status. Consequently, interpretation could be difficult during the acute phase immediately after the transplant. Moreover, the role of transthyretin in monitoring the hepatic synthetic function in liver transplant is discussed. In conclusion, transthyretin is a reliable indicator of nutritional status in transplant candidates and potentially useful in the post-transplant phase if the inflammatory status is taken into account.

Biomarkers↗

[Nutrition and tumoral growth].

Some nutrients, such as glutamine, arginine, omega-3 fatty acids and nucleotides have been shown to modulate the immune and intestinal systems. They affect the synthesis of proteins and the expression of enzymes, as well as the activation and the proliferation of leukocytes and enterocytes. Since these immunonutrients modulate the response of tissues with rapid cell turnover, such as spleen, thymus, bone marrow and intestinal mucosa, they may also affect, such as suggested by some preliminary results, cancer cell proliferation and tumour growth. Therefore, further investigations are needed to understand the underlying mechanisms and to determine possible advantages and limitations of their administration to cancer patients.

Animals↗

[Modulation of immunity in cancerous patient : an weapon with double edges?].

Nutritional support of cancer patients should ideally contribute to improve the immune defence, maintain the protein body pool and sensitize the tumour to oncologic treatments. Such a goal is not easy to achieve, because any nutritional support efficient at stimulating immune response and protein syntheses might also simultaneously stimulate the tumour growth. Contradictory observations have been reported for several nutrients contained in the nutritive solutions available on the market. This is the case for glutamine, arginine, omega-3 fatty acids and nucleotides. Their clinical use during oncologic therapies deserves further testing and analysis.

Animals↗

[ Evaluation of the nutritional state of patients in emergency services: contribution in measurement of body composition].

Weight and body mass index are used in clinical routine to detect malnourished patients. However, a study performed at the emergency admission of the University Hospital of Geneva shows that the prevalence of malnutrition is very underestimated when based on body mass index instead of fat-free mass. Indeed, a third of the patients with normal body mass index, i.e. between 20 and 24.9 kg/m2, present a fat-free mass under percentile 10. This suggests that the body mass index alone cannot be used as diagnostic criteria for malnutrition. This review describes the prevalence of malnutrition at the emergency admission of the University Hospital of Geneva, the prevalence of malnutrition in the literature and its relationship with length of hospital stay and mortality.

Anthropometry↗

[Parenteral nutrition in the Swiss hospitals: a three years national survey].

Total parenteral nutrition (TPN) requires the perfusion of more than 40 compounds (glucose, amino acids, lipids, electrolytes, vitamins and trace elements). Many systems of application are used. With the help of pharmacists, the current types of products and methods of TPN administration, as well as the evolution of TPN practice were evaluated in the Swiss hospitals during three consecutive years. Six different TPN systems are commonly used for adult patients. All lead to the administration of TPN in "all-in-one" admixtures. For adults, formula compounding is provided in large hospitals only. For pediatric TPN, formula compounding is routinely performed in the hospitals because individualized compositions are not available commercially. Regarding TPN-admixtures outpatients, they are mostly compounded in hospital pharmacies and delivered by 3 large hospitals. Compositions of TPN formula comply, on average, with European guidelines. An increased number of multidisciplinary nutritional support teams is still necessary to optimize the medical and economical management of TPN.

Adult↗

[Microgravity and weightlessness: experimental model accelerates nutritional pathology].

Short space flights affect nutritional intakes, body composition and functional parameters. Prolonged space flights (SF) over weeks or months further worsen these alterations and result in acute or chronic physical deterioration at earth return. Current planning of SF to Mars, with microgravity conditions for more than 2 years, stresses the need for developing and optimising a nutritional program and physical countermeasures to prevent body mass atrophy and functional body alterations. This review presents the models of microgravity simulation on earth and the main effects of weightlessness on body composition, protein metabolism, hormonal profile and muscle function. It summarizes contradictory findings related to the oxidative stress related to SF. It discusses potential countermeasures (nutrition, physical activity) to the negative effects of microgravity on human body. Future research possibilities in ground and space medicine are evoked.

Aerospace Medicine↗

Weight-losing HIV-infected patients on recombinant human growth hormone for 12 wk: a national study.

OBJECTIVE: In patients with human immunodeficiency virus, body weight (BW) loss, due mainly to loss of fat-free mass, is associated with progression of disease and mortality. Recombinant human growth hormone (rhGH) may promote BW gain by restoring FFM. METHODS: We investigated the results of adding to highly active antiretroviral therapy of routine rhGH treatment in 34 patients with human immunodeficiency virus who had lost 5% to 20% of their usual BWs. They were recruited by their physicians in Switzerland and were instructed to self-administer the drug. Patients were given 6 mg of rhGH each day for 12 wk. BW and body composition, measured by bioelectrical impedance analysis (50 kHz, tetrapolar), were recorded at baseline and at 4, 8, and 12 wk of treatment. RESULTS: At week 12, BW gain averaged 3.0 +/- 0.5 kg (P < 0.001), fat-free mass gain was 4.8 +/- 0.5 kg (P = 0.001), and body fat mass loss was 1.8 +/- 0.4 kg (P = 0.008). BW and fat-free mass increases and FM decrease were evident by week 4 and tended to plateau by week 8. Therapy was well tolerated; one patient developed carpal tunnel syndrome. Five patients abandoned the study for reasons unrelated to the rhGH treatment. CONCLUSION: Our data strongly support the use of rhGH in the treatment of unintentional BW loss associated with human immunodeficiency virus. The low rate of dropouts and the low incidence of side effects make the use of rhGH suitable for primary care management.

Antiretroviral Therapy, Highly Active↗

Body composition interpretation. Contributions of the fat-free mass index and the body fat mass index.

OBJECTIVE: Low and high body mass index (BMI) values have been shown to increase health risks and mortality and result in variations in fat-free mass (FFM) and body fat mass (BF). Currently, there are no published ranges for a fat-free mass index (FFMI; kg/m(2)), a body fat mass index (BFMI; kg/m(2)), and percentage of body fat (%BF). The purpose of this population study was to determine predicted FFMI and BFMI values in subjects with low, normal, overweight, and obese BMI. METHODS: FFM and BF were determined in 2986 healthy white men and 2649 white women, age 15 to 98 y, by a previously validated 50-kHz bioelectrical impedance analysis equation. FFMI, BFMI, and %BF were calculated. RESULTS: FFMI values were 16.7 to 19.8 kg/m(2) for men and 14.6 to 16.8 kg/m(2) for women within the normal BMI ranges. BFMI values were 1.8 to 5.2 kg/m(2) for men and 3.9 to 8.2 kg/m(2) for women within the normal BMI ranges. BFMI values were 8.3 and 11.8 kg/m(2) in men and women, respectively, for obese BMI (>30 kg/m(2)). Normal ranges for %BF were 13.4 to 21.7 and 24.6 to 33.2 for men and women, respectively. CONCLUSION: BMI alone cannot provide information about the respective contribution of FFM or fat mass to body weight. This study presents FFMI and BFMI values that correspond to low, normal, overweight, and obese BMIs. FFMI and BFMI provide information about body compartments, regardless of height.

Adipose Tissue↗

Physical characteristics of total parenteral nutrition bags significantly affect the stability of vitamins C and B1: a controlled prospective study.

BACKGROUND: Vitamin degradation occurring during the storage of total parenteral nutrition (TPN) mixtures is significant and affects clinical outcome. This study aimed to assess the influence of the TPN bag material, the temperature, and the duration of storage on the stability of different vitamins. METHODS: Solutions of multivitamin and trace elements at recommended doses were injected into either an ethylvinyl acetate (EVA) bag or a multilayered (ML) bag filled with 2500 mL of an identical mixture of carbohydrates (1200 kcal), fat (950 kcal), and amino acids (380 kcal). The bags were then stored at 4 degrees C, 21 degrees C, or 40 degrees C. Concentrations of vitamins A, B1, C, and E were measured up to 72 hours after compounding, using high-pressure liquid chromatography. RESULTS: Ten percent to 30% of vitamin C degradation occurred within the first minutes after TPN compounding. Vitamin C was more stable in ML bags (half-life: 68.6 hours at 4 degrees C, 24.4 hours at 21 degrees C, and 6.8 hours at 40 degrees C) than in EVA bags (half-life: 7.2 hours at 4 degrees C, 3.2 hours at 21 degrees C, and 1.1 hour at 40 degrees C). Moreover, appearance of dehydroascorbic acid in the TPN mixture did not compensate for vitamin C losses. Vitamin B1 was stable at 21 degrees C, but a 43% loss occurred at 40 degrees C after 72-hour storage in EVA bags. The other vitamins were stable in the TPN mixture stored in both bags at any temperature and without daylight protection. CONCLUSIONS: Degradations of vitamins C and B, are significantly reduced in ML bags compared with EVA bags. To prevent vitamin C deficiencies, its initial dose should be adapted to its degradation rate, which depends on the TPN bag material, the ambient temperature, and the length of time between TPN compounding and the end of infusion to the patient.

Ascorbic Acid↗

Is nutritional depletion by Nutritional Risk Index associated with increased length of hospital stay? A population-based study.

BACKGROUND: Malnutrition is common at hospital admission and tends to worsen during hospitalization. This controlled population study aimed to determine if serum albumin or moderate and severe nutritional depletion by Nutritional Risk Index (NRI) at hospital admission are associated with increased length of hospital stay (LOS) (and increased hospital cost) in patients admitted to hospitals in 2 European countries. METHODS: Serum albumin levels and recent weight loss were prospectively determined at hospital admission in Geneva (n = 652) and Berlin (n = 621). Patients were classified as no, mild, moderate or severe risk by NRI. Multiple logistic regressions were used to determine the association between albumin and nutritional risk category and LOS. RESULTS: Patients (24%) were at moderate or severe nutritional risk by NRI. Nutritional risk by NRI, adjusted for age, was associated with LOS of 11 days (moderate: odds ratio [OR] 1.9, 95% confidence interval [CI] 1.4 to 2.7, p < .005; severe: OR 2.9, 95% CI 1.6 to 5.3, p < .005). Serum albumin was also significantly associated with increased LOS (p < .001). CONCLUSIONS: The prevalence of nutritional depletion assessed by NRI and albumin was increased with longer LOS. Albumin alone underestimated nutritional risk. Severe nutritional depletion by NRI was significantly associated with LOS > or = 11 days in Geneva and Berlin patients. Nutrition screening should take place at hospital admission to determine nutritional risk and risk for longer LOS.

Aged↗

Assessment of ascorbic acid stability in different multilayered parenteral nutrition bags: critical influence of the bag wall material.

BACKGROUND: The recent development of multilayered bags has minimized ascorbic acid oxidation in parenteral nutrition (PN) admixtures. However, the gas-barrier property of multilayered bags depends on their plastic material. This study compared ascorbic acid stability in different multilayered bags under experimental conditions. METHODS: Oxygen permeability of a newly developed 6-layered bag (6-L) was compared with a highly mechanical-resistant 3-layered bag (3-L(R)) and a highly flexible 3-layered bag (3-L(F)) using gas chromatography. Ascorbic acid stability was assessed by iodine titration in bags filled with 2.5 L H(2)O and 40 g carbohydrates after setting residual O(2) content at < or =1 or > or =5 ppm. The effect of storage at 4 degrees C, 21 degrees C, and 40 degrees C on ascorbic acid stability was assessed over 48 hours in a complete PN admixture (ie, 330 g carbohydrates, 100 g lipids, 96 g amino acids and trace elements) using high-pressure liquid chromatography. RESULTS: Oxygen permeability was markedly reduced in 6-L bags (0.5 mL O(2) /m(2)/d) compared with 3-L(R) (150 mL O(2) /m(2)/d) and 3-L(R) (1500 mL O(2)/m(2)/d). Accordingly, ascorbic acid was more stable in 6-L bags (half-life [T(1/2)] = 16 days up to 40 degrees C) than in 3-L(R) (T(1/2) = 9 days at 4 degrees C, 47 hours at 21 degrees C and 29 hours at 40 degrees C) and 3-L(F) (T(1/2) = 15 hours at 4 degrees C, 10 hours at 21 degrees C, and 6 hours at 40 degrees C). During the first 6 hours after PN admixture compounding, an additive ascorbic acid loss of 4.6 +/- 0.5 mg/L/ppm O(2) occurred because of residual O(2) in the bag. CONCLUSIONS: The new combination of plastic layers and careful O(2) monitoring during the filling process allowed near to complete prevention of ascorbic acid degradation in multilayered PN bags during 48 hours, regardless of the storage temperature.

Ascorbic Acid↗